nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—Neuritis—Vincristine—sarcoma	0.0175	0.0188	CcSEcCtD
Cyproheptadine—CHRM3—muscle of abdomen—sarcoma	0.0151	0.217	CbGeAlD
Cyproheptadine—Chest discomfort—Etoposide—sarcoma	0.012	0.0129	CcSEcCtD
Cyproheptadine—Hepatic failure—Thiotepa—sarcoma	0.0119	0.0128	CcSEcCtD
Cyproheptadine—Hepatic failure—Dactinomycin—sarcoma	0.0118	0.0127	CcSEcCtD
Cyproheptadine—Hepatic failure—Vincristine—sarcoma	0.0106	0.0113	CcSEcCtD
Cyproheptadine—Urinary retention—Thiotepa—sarcoma	0.0102	0.0109	CcSEcCtD
Cyproheptadine—Urinary retention—Vincristine—sarcoma	0.00902	0.00969	CcSEcCtD
Cyproheptadine—Weight increased—Thiotepa—sarcoma	0.00841	0.00904	CcSEcCtD
Cyproheptadine—Jaundice—Thiotepa—sarcoma	0.00803	0.00863	CcSEcCtD
Cyproheptadine—Neuritis—Epirubicin—sarcoma	0.00795	0.00854	CcSEcCtD
Cyproheptadine—Sweating increased—Mitoxantrone—sarcoma	0.00777	0.00836	CcSEcCtD
Cyproheptadine—Agranulocytosis—Thiotepa—sarcoma	0.00769	0.00827	CcSEcCtD
Cyproheptadine—Agranulocytosis—Dactinomycin—sarcoma	0.00763	0.0082	CcSEcCtD
Cyproheptadine—HTR2A—pulmonary artery—sarcoma	0.0076	0.109	CbGeAlD
Cyproheptadine—Photosensitivity reaction—Vincristine—sarcoma	0.00748	0.00804	CcSEcCtD
Cyproheptadine—Hallucination—Thiotepa—sarcoma	0.00736	0.00791	CcSEcCtD
Cyproheptadine—Neuritis—Doxorubicin—sarcoma	0.00735	0.0079	CcSEcCtD
Cyproheptadine—Hepatitis—Dactinomycin—sarcoma	0.00734	0.00789	CcSEcCtD
Cyproheptadine—Weight increased—Mitoxantrone—sarcoma	0.00726	0.00781	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Vincristine—sarcoma	0.00716	0.0077	CcSEcCtD
Cyproheptadine—Drowsiness—Mitoxantrone—sarcoma	0.00712	0.00765	CcSEcCtD
Cyproheptadine—Jaundice—Mitoxantrone—sarcoma	0.00694	0.00746	CcSEcCtD
Cyproheptadine—Tinnitus—Thiotepa—sarcoma	0.0069	0.00741	CcSEcCtD
Cyproheptadine—Agranulocytosis—Mitoxantrone—sarcoma	0.00664	0.00714	CcSEcCtD
Cyproheptadine—Chills—Thiotepa—sarcoma	0.00664	0.00713	CcSEcCtD
Cyproheptadine—Chills—Dactinomycin—sarcoma	0.00659	0.00708	CcSEcCtD
Cyproheptadine—Hallucination—Vincristine—sarcoma	0.00653	0.00702	CcSEcCtD
Cyproheptadine—Sweating increased—Etoposide—sarcoma	0.00647	0.00695	CcSEcCtD
Cyproheptadine—Hepatitis—Mitoxantrone—sarcoma	0.00639	0.00687	CcSEcCtD
Cyproheptadine—Tension—Thiotepa—sarcoma	0.00632	0.00679	CcSEcCtD
Cyproheptadine—Nervousness—Thiotepa—sarcoma	0.00625	0.00672	CcSEcCtD
Cyproheptadine—Vision blurred—Thiotepa—sarcoma	0.00607	0.00652	CcSEcCtD
Cyproheptadine—Agitation—Thiotepa—sarcoma	0.00592	0.00636	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Etoposide—sarcoma	0.0058	0.00624	CcSEcCtD
Cyproheptadine—Jaundice—Etoposide—sarcoma	0.00577	0.0062	CcSEcCtD
Cyproheptadine—Leukopenia—Thiotepa—sarcoma	0.00576	0.0062	CcSEcCtD
Cyproheptadine—Chills—Mitoxantrone—sarcoma	0.00573	0.00616	CcSEcCtD
Cyproheptadine—Leukopenia—Dactinomycin—sarcoma	0.00572	0.00615	CcSEcCtD
Cyproheptadine—Convulsion—Thiotepa—sarcoma	0.00558	0.006	CcSEcCtD
Cyproheptadine—Agranulocytosis—Etoposide—sarcoma	0.00552	0.00594	CcSEcCtD
Cyproheptadine—Confusional state—Thiotepa—sarcoma	0.0053	0.0057	CcSEcCtD
Cyproheptadine—Agitation—Vincristine—sarcoma	0.00525	0.00564	CcSEcCtD
Cyproheptadine—Vision blurred—Mitoxantrone—sarcoma	0.00524	0.00563	CcSEcCtD
Cyproheptadine—Oedema—Dactinomycin—sarcoma	0.00522	0.00561	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Thiotepa—sarcoma	0.00515	0.00553	CcSEcCtD
Cyproheptadine—Vertigo—Vincristine—sarcoma	0.00513	0.00551	CcSEcCtD
Cyproheptadine—Tachycardia—Thiotepa—sarcoma	0.00513	0.00551	CcSEcCtD
Cyproheptadine—Leukopenia—Vincristine—sarcoma	0.00511	0.00549	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Dactinomycin—sarcoma	0.00511	0.00549	CcSEcCtD
Cyproheptadine—Anorexia—Thiotepa—sarcoma	0.00501	0.00539	CcSEcCtD
Cyproheptadine—Leukopenia—Mitoxantrone—sarcoma	0.00498	0.00535	CcSEcCtD
Cyproheptadine—Anorexia—Dactinomycin—sarcoma	0.00497	0.00534	CcSEcCtD
Cyproheptadine—Convulsion—Vincristine—sarcoma	0.00495	0.00532	CcSEcCtD
Cyproheptadine—Photosensitivity—Epirubicin—sarcoma	0.0049	0.00527	CcSEcCtD
Cyproheptadine—Convulsion—Mitoxantrone—sarcoma	0.00482	0.00518	CcSEcCtD
Cyproheptadine—Hepatic failure—Epirubicin—sarcoma	0.00479	0.00515	CcSEcCtD
Cyproheptadine—Chills—Etoposide—sarcoma	0.00477	0.00513	CcSEcCtD
Cyproheptadine—Paraesthesia—Thiotepa—sarcoma	0.00472	0.00507	CcSEcCtD
Cyproheptadine—Somnolence—Thiotepa—sarcoma	0.00467	0.00502	CcSEcCtD
Cyproheptadine—Oedema—Vincristine—sarcoma	0.00466	0.00501	CcSEcCtD
Cyproheptadine—Dyspepsia—Thiotepa—sarcoma	0.00463	0.00497	CcSEcCtD
Cyproheptadine—HTR2A—hindlimb—sarcoma	0.0046	0.066	CbGeAlD
Cyproheptadine—Increased appetite—Epirubicin—sarcoma	0.00458	0.00493	CcSEcCtD
Cyproheptadine—Confusional state—Mitoxantrone—sarcoma	0.00458	0.00492	CcSEcCtD
Cyproheptadine—Decreased appetite—Thiotepa—sarcoma	0.00457	0.00491	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Vincristine—sarcoma	0.00456	0.0049	CcSEcCtD
Cyproheptadine—Oedema—Mitoxantrone—sarcoma	0.00454	0.00488	CcSEcCtD
Cyproheptadine—Photosensitivity—Doxorubicin—sarcoma	0.00454	0.00488	CcSEcCtD
Cyproheptadine—Decreased appetite—Dactinomycin—sarcoma	0.00453	0.00487	CcSEcCtD
Cyproheptadine—Fatigue—Thiotepa—sarcoma	0.00453	0.00487	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Vincristine—sarcoma	0.00451	0.00484	CcSEcCtD
Cyproheptadine—Fatigue—Dactinomycin—sarcoma	0.0045	0.00483	CcSEcCtD
Cyproheptadine—Constipation—Thiotepa—sarcoma	0.00449	0.00483	CcSEcCtD
Cyproheptadine—Shock—Mitoxantrone—sarcoma	0.00447	0.0048	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00444	0.00478	CcSEcCtD
Cyproheptadine—Anorexia—Vincristine—sarcoma	0.00444	0.00478	CcSEcCtD
Cyproheptadine—Hepatic failure—Doxorubicin—sarcoma	0.00443	0.00477	CcSEcCtD
Cyproheptadine—Tachycardia—Mitoxantrone—sarcoma	0.00443	0.00476	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00439	0.00472	CcSEcCtD
Cyproheptadine—Hypotension—Vincristine—sarcoma	0.00435	0.00468	CcSEcCtD
Cyproheptadine—Feeling abnormal—Thiotepa—sarcoma	0.00433	0.00466	CcSEcCtD
Cyproheptadine—Anorexia—Mitoxantrone—sarcoma	0.00433	0.00465	CcSEcCtD
Cyproheptadine—Diplopia—Epirubicin—sarcoma	0.00431	0.00463	CcSEcCtD
Cyproheptadine—Feeling abnormal—Dactinomycin—sarcoma	0.0043	0.00462	CcSEcCtD
Cyproheptadine—Hypotension—Mitoxantrone—sarcoma	0.00424	0.00456	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—sarcoma	0.00424	0.00456	CcSEcCtD
Cyproheptadine—Insomnia—Vincristine—sarcoma	0.00422	0.00453	CcSEcCtD
Cyproheptadine—Paraesthesia—Vincristine—sarcoma	0.00418	0.0045	CcSEcCtD
Cyproheptadine—Urticaria—Thiotepa—sarcoma	0.00418	0.00449	CcSEcCtD
Cyproheptadine—Vertigo—Etoposide—sarcoma	0.00416	0.00447	CcSEcCtD
Cyproheptadine—Leukopenia—Etoposide—sarcoma	0.00414	0.00445	CcSEcCtD
Cyproheptadine—Paraesthesia—Mitoxantrone—sarcoma	0.00408	0.00438	CcSEcCtD
Cyproheptadine—Loss of consciousness—Etoposide—sarcoma	0.00407	0.00437	CcSEcCtD
Cyproheptadine—Decreased appetite—Vincristine—sarcoma	0.00405	0.00435	CcSEcCtD
Cyproheptadine—Somnolence—Mitoxantrone—sarcoma	0.00404	0.00434	CcSEcCtD
Cyproheptadine—Fatigue—Vincristine—sarcoma	0.00402	0.00432	CcSEcCtD
Cyproheptadine—Convulsion—Etoposide—sarcoma	0.00401	0.00431	CcSEcCtD
Cyproheptadine—Dyspepsia—Mitoxantrone—sarcoma	0.004	0.00429	CcSEcCtD
Cyproheptadine—Constipation—Vincristine—sarcoma	0.00399	0.00428	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—sarcoma	0.00398	0.00428	CcSEcCtD
Cyproheptadine—Decreased appetite—Mitoxantrone—sarcoma	0.00395	0.00424	CcSEcCtD
Cyproheptadine—HTR2A—appendage—sarcoma	0.00394	0.0566	CbGeAlD
Cyproheptadine—Fatigue—Mitoxantrone—sarcoma	0.00391	0.00421	CcSEcCtD
Cyproheptadine—Constipation—Mitoxantrone—sarcoma	0.00388	0.00417	CcSEcCtD
Cyproheptadine—Confusional state—Etoposide—sarcoma	0.00381	0.00409	CcSEcCtD
Cyproheptadine—Asthenia—Thiotepa—sarcoma	0.00377	0.00405	CcSEcCtD
Cyproheptadine—Asthenia—Dactinomycin—sarcoma	0.00374	0.00402	CcSEcCtD
Cyproheptadine—Feeling abnormal—Mitoxantrone—sarcoma	0.00374	0.00402	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Etoposide—sarcoma	0.0037	0.00397	CcSEcCtD
Cyproheptadine—Tachycardia—Etoposide—sarcoma	0.00368	0.00396	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Etoposide—sarcoma	0.00365	0.00392	CcSEcCtD
Cyproheptadine—Urticaria—Mitoxantrone—sarcoma	0.00361	0.00388	CcSEcCtD
Cyproheptadine—Anorexia—Etoposide—sarcoma	0.0036	0.00387	CcSEcCtD
Cyproheptadine—Diarrhoea—Thiotepa—sarcoma	0.0036	0.00387	CcSEcCtD
Cyproheptadine—UGT1A3—liver—sarcoma	0.00358	0.0514	CbGeAlD
Cyproheptadine—Diarrhoea—Dactinomycin—sarcoma	0.00357	0.00384	CcSEcCtD
Cyproheptadine—Hypotension—Etoposide—sarcoma	0.00353	0.00379	CcSEcCtD
Cyproheptadine—Dizziness—Thiotepa—sarcoma	0.00348	0.00374	CcSEcCtD
Cyproheptadine—Pollakiuria—Epirubicin—sarcoma	0.00344	0.0037	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Epirubicin—sarcoma	0.0034	0.00365	CcSEcCtD
Cyproheptadine—Paraesthesia—Etoposide—sarcoma	0.00339	0.00364	CcSEcCtD
Cyproheptadine—Weight increased—Epirubicin—sarcoma	0.00339	0.00364	CcSEcCtD
Cyproheptadine—Somnolence—Etoposide—sarcoma	0.00336	0.00361	CcSEcCtD
Cyproheptadine—Asthenia—Vincristine—sarcoma	0.00334	0.00359	CcSEcCtD
Cyproheptadine—Vomiting—Thiotepa—sarcoma	0.00334	0.00359	CcSEcCtD
Cyproheptadine—Drowsiness—Epirubicin—sarcoma	0.00332	0.00357	CcSEcCtD
Cyproheptadine—Vomiting—Dactinomycin—sarcoma	0.00332	0.00357	CcSEcCtD
Cyproheptadine—Rash—Thiotepa—sarcoma	0.00331	0.00356	CcSEcCtD
Cyproheptadine—Dermatitis—Thiotepa—sarcoma	0.00331	0.00356	CcSEcCtD
Cyproheptadine—Headache—Thiotepa—sarcoma	0.00329	0.00354	CcSEcCtD
Cyproheptadine—Rash—Dactinomycin—sarcoma	0.00329	0.00354	CcSEcCtD
Cyproheptadine—Decreased appetite—Etoposide—sarcoma	0.00328	0.00353	CcSEcCtD
Cyproheptadine—Asthenia—Mitoxantrone—sarcoma	0.00326	0.0035	CcSEcCtD
Cyproheptadine—Fatigue—Etoposide—sarcoma	0.00325	0.0035	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Epirubicin—sarcoma	0.00325	0.0035	CcSEcCtD
Cyproheptadine—Jaundice—Epirubicin—sarcoma	0.00323	0.00348	CcSEcCtD
Cyproheptadine—Constipation—Etoposide—sarcoma	0.00323	0.00347	CcSEcCtD
Cyproheptadine—Diarrhoea—Vincristine—sarcoma	0.00319	0.00343	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—sarcoma	0.00318	0.00342	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—sarcoma	0.00314	0.00338	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—sarcoma	0.00313	0.00337	CcSEcCtD
Cyproheptadine—Nausea—Thiotepa—sarcoma	0.00312	0.00336	CcSEcCtD
Cyproheptadine—Feeling abnormal—Etoposide—sarcoma	0.00311	0.00334	CcSEcCtD
Cyproheptadine—Diarrhoea—Mitoxantrone—sarcoma	0.00311	0.00334	CcSEcCtD
Cyproheptadine—Nausea—Dactinomycin—sarcoma	0.0031	0.00333	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—sarcoma	0.0031	0.00333	CcSEcCtD
Cyproheptadine—Dizziness—Vincristine—sarcoma	0.00308	0.00331	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—sarcoma	0.00307	0.0033	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—sarcoma	0.00301	0.00323	CcSEcCtD
Cyproheptadine—Urticaria—Etoposide—sarcoma	0.003	0.00322	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—sarcoma	0.00299	0.00322	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—sarcoma	0.00298	0.0032	CcSEcCtD
Cyproheptadine—Vomiting—Vincristine—sarcoma	0.00296	0.00319	CcSEcCtD
Cyproheptadine—Rash—Vincristine—sarcoma	0.00294	0.00316	CcSEcCtD
Cyproheptadine—Dermatitis—Vincristine—sarcoma	0.00294	0.00316	CcSEcCtD
Cyproheptadine—Headache—Vincristine—sarcoma	0.00292	0.00314	CcSEcCtD
Cyproheptadine—Vomiting—Mitoxantrone—sarcoma	0.00289	0.0031	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—sarcoma	0.00287	0.00308	CcSEcCtD
Cyproheptadine—Rash—Mitoxantrone—sarcoma	0.00286	0.00308	CcSEcCtD
Cyproheptadine—Dermatitis—Mitoxantrone—sarcoma	0.00286	0.00307	CcSEcCtD
Cyproheptadine—Headache—Mitoxantrone—sarcoma	0.00284	0.00306	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—sarcoma	0.00278	0.00299	CcSEcCtD
Cyproheptadine—Nausea—Vincristine—sarcoma	0.00277	0.00298	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—sarcoma	0.00276	0.00296	CcSEcCtD
Cyproheptadine—Asthenia—Etoposide—sarcoma	0.00271	0.00291	CcSEcCtD
Cyproheptadine—Nausea—Mitoxantrone—sarcoma	0.0027	0.0029	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—sarcoma	0.00267	0.00287	CcSEcCtD
Cyproheptadine—Diarrhoea—Etoposide—sarcoma	0.00258	0.00278	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—sarcoma	0.00257	0.00276	CcSEcCtD
Cyproheptadine—HTR2B—myometrium—sarcoma	0.00255	0.0366	CbGeAlD
Cyproheptadine—Tension—Epirubicin—sarcoma	0.00254	0.00274	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—sarcoma	0.00252	0.00271	CcSEcCtD
Cyproheptadine—Dizziness—Etoposide—sarcoma	0.0025	0.00268	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—sarcoma	0.00247	0.00266	CcSEcCtD
Cyproheptadine—Vision blurred—Epirubicin—sarcoma	0.00244	0.00263	CcSEcCtD
Cyproheptadine—Vomiting—Etoposide—sarcoma	0.0024	0.00258	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—sarcoma	0.00238	0.00256	CcSEcCtD
Cyproheptadine—HTR2A—endothelium—sarcoma	0.00238	0.0342	CbGeAlD
Cyproheptadine—Rash—Etoposide—sarcoma	0.00238	0.00256	CcSEcCtD
Cyproheptadine—Dermatitis—Etoposide—sarcoma	0.00238	0.00256	CcSEcCtD
Cyproheptadine—Headache—Etoposide—sarcoma	0.00237	0.00254	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—sarcoma	0.00235	0.00253	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—sarcoma	0.00233	0.0025	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—sarcoma	0.00233	0.0025	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—sarcoma	0.00233	0.0025	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—sarcoma	0.00232	0.00249	CcSEcCtD
Cyproheptadine—Palpitations—Epirubicin—sarcoma	0.00229	0.00246	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—sarcoma	0.00228	0.00245	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—sarcoma	0.00226	0.00243	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—sarcoma	0.00225	0.00241	CcSEcCtD
Cyproheptadine—Nausea—Etoposide—sarcoma	0.00224	0.00241	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—sarcoma	0.0022	0.00237	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—sarcoma	0.00216	0.00232	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—sarcoma	0.00215	0.00231	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—sarcoma	0.00215	0.00231	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—sarcoma	0.00213	0.00229	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—sarcoma	0.00212	0.00228	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—sarcoma	0.00212	0.00227	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—sarcoma	0.00211	0.00227	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—sarcoma	0.00208	0.00224	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—sarcoma	0.00208	0.00223	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—sarcoma	0.00207	0.00223	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—sarcoma	0.00207	0.00222	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Epirubicin—sarcoma	0.00205	0.0022	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—sarcoma	0.00202	0.00217	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—sarcoma	0.00198	0.00213	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—sarcoma	0.00197	0.00212	CcSEcCtD
Cyproheptadine—HTR1A—hematopoietic system—sarcoma	0.00196	0.0282	CbGeAlD
Cyproheptadine—Oedema—Doxorubicin—sarcoma	0.00196	0.0021	CcSEcCtD
Cyproheptadine—HTR2B—smooth muscle tissue—sarcoma	0.00193	0.0277	CbGeAlD
Cyproheptadine—Shock—Doxorubicin—sarcoma	0.00193	0.00207	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—sarcoma	0.00192	0.00206	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—sarcoma	0.00191	0.00206	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—sarcoma	0.00191	0.00205	CcSEcCtD
Cyproheptadine—HTR2B—skin of body—sarcoma	0.0019	0.0273	CbGeAlD
Cyproheptadine—Paraesthesia—Epirubicin—sarcoma	0.0019	0.00204	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—sarcoma	0.00189	0.00203	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—sarcoma	0.00188	0.00202	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—sarcoma	0.00187	0.00201	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—sarcoma	0.00186	0.002	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—sarcoma	0.00184	0.00198	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—sarcoma	0.00183	0.00197	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—sarcoma	0.00182	0.00196	CcSEcCtD
Cyproheptadine—Constipation—Epirubicin—sarcoma	0.00181	0.00195	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—sarcoma	0.00177	0.0019	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—sarcoma	0.00176	0.00189	CcSEcCtD
Cyproheptadine—Feeling abnormal—Epirubicin—sarcoma	0.00174	0.00187	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—sarcoma	0.00174	0.00187	CcSEcCtD
Cyproheptadine—CHRM3—smooth muscle tissue—sarcoma	0.00173	0.0249	CbGeAlD
Cyproheptadine—Dyspepsia—Doxorubicin—sarcoma	0.00172	0.00185	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—sarcoma	0.0017	0.00183	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—sarcoma	0.00169	0.00181	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—sarcoma	0.00168	0.00181	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—sarcoma	0.00167	0.0018	CcSEcCtD
Cyproheptadine—HTR2B—uterus—sarcoma	0.00165	0.0237	CbGeAlD
Cyproheptadine—HRH1—myometrium—sarcoma	0.00163	0.0234	CbGeAlD
Cyproheptadine—Feeling abnormal—Doxorubicin—sarcoma	0.00161	0.00173	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—sarcoma	0.00156	0.00167	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—sarcoma	0.00152	0.00163	CcSEcCtD
Cyproheptadine—HTR2B—tendon—sarcoma	0.00145	0.0208	CbGeAlD
Cyproheptadine—Diarrhoea—Epirubicin—sarcoma	0.00145	0.00156	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—sarcoma	0.0014	0.00151	CcSEcCtD
Cyproheptadine—HRH1—hematopoietic system—sarcoma	0.0014	0.0201	CbGeAlD
Cyproheptadine—Dizziness—Epirubicin—sarcoma	0.0014	0.0015	CcSEcCtD
Cyproheptadine—HRH1—connective tissue—sarcoma	0.00135	0.0193	CbGeAlD
Cyproheptadine—Vomiting—Epirubicin—sarcoma	0.00135	0.00145	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—sarcoma	0.00134	0.00144	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—sarcoma	0.00133	0.00143	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—sarcoma	0.00133	0.00143	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—sarcoma	0.00133	0.00143	CcSEcCtD
Cyproheptadine—HTR2A—embryo—sarcoma	0.00131	0.0188	CbGeAlD
Cyproheptadine—Dizziness—Doxorubicin—sarcoma	0.00129	0.00139	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—sarcoma	0.00126	0.00135	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—sarcoma	0.00125	0.00134	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—sarcoma	0.00123	0.00133	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—sarcoma	0.00123	0.00133	CcSEcCtD
Cyproheptadine—HRH1—smooth muscle tissue—sarcoma	0.00123	0.0177	CbGeAlD
Cyproheptadine—Headache—Doxorubicin—sarcoma	0.00123	0.00132	CcSEcCtD
Cyproheptadine—HTR2A—hematopoietic system—sarcoma	0.00117	0.0168	CbGeAlD
Cyproheptadine—Nausea—Doxorubicin—sarcoma	0.00116	0.00125	CcSEcCtD
Cyproheptadine—HTR2A—connective tissue—sarcoma	0.00113	0.0162	CbGeAlD
Cyproheptadine—CHRM3—testis—sarcoma	0.00108	0.0155	CbGeAlD
Cyproheptadine—SLC6A2—testis—sarcoma	0.00107	0.0153	CbGeAlD
Cyproheptadine—HTR2A—smooth muscle tissue—sarcoma	0.00103	0.0148	CbGeAlD
Cyproheptadine—DRD2—testis—sarcoma	0.000971	0.0139	CbGeAlD
Cyproheptadine—HRH1—tendon—sarcoma	0.000926	0.0133	CbGeAlD
Cyproheptadine—HTR2B—lymph node—sarcoma	0.00087	0.0125	CbGeAlD
Cyproheptadine—HTR2A—tendon—sarcoma	0.000774	0.0111	CbGeAlD
Cyproheptadine—SLC6A2—lymph node—sarcoma	0.000773	0.0111	CbGeAlD
Cyproheptadine—HRH1—testis—sarcoma	0.000767	0.011	CbGeAlD
Cyproheptadine—HTR2A—testis—sarcoma	0.000641	0.0092	CbGeAlD
Cyproheptadine—HTR2A—liver—sarcoma	0.000606	0.00869	CbGeAlD
Cyproheptadine—HRH1—lymph node—sarcoma	0.000556	0.00798	CbGeAlD
